MRF-Logo2019-Horizontal-RGB
Scuba Doc
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

Scuba Doc

Forum Replies Created

Viewing 1 reply thread
1 2 3 4
  • Replies
      • September 18, 2014 at 12:18 pm
      Scuba Doc
      Participant

        If you have no other options ( Yervoy, PD-1 etc. ) the NRAS mutation can be treated with "Mekinist" ( trametinib ) in an 'off label' prescription here in the US. We have been approved by Humana Ins. with a small co-pay. 

        • September 18, 2014 at 12:18 pm
        Scuba Doc
        Participant

          If you have no other options ( Yervoy, PD-1 etc. ) the NRAS mutation can be treated with "Mekinist" ( trametinib ) in an 'off label' prescription here in the US. We have been approved by Humana Ins. with a small co-pay. 

          • September 18, 2014 at 12:18 pm
          Scuba Doc
          Participant

            If you have no other options ( Yervoy, PD-1 etc. ) the NRAS mutation can be treated with "Mekinist" ( trametinib ) in an 'off label' prescription here in the US. We have been approved by Humana Ins. with a small co-pay. 

            • September 9, 2014 at 12:03 pm
            Scuba Doc
            Participant

              Dr. Keith Flaherty at MGH, Boston —- responds very quickly to e-mails–[email protected]

              • September 9, 2014 at 12:03 pm
              Scuba Doc
              Participant

                Dr. Keith Flaherty at MGH, Boston —- responds very quickly to e-mails–[email protected]

                • September 9, 2014 at 12:03 pm
                Scuba Doc
                Participant

                  Dr. Keith Flaherty at MGH, Boston —- responds very quickly to e-mails–[email protected]

                  • September 4, 2014 at 8:54 pm
                  Scuba Doc
                  Participant

                    Pembrolizumab works just as well as a first line treatment — I wonder if  doctors will be able to get it 'Off Label" soon? And if insurance companies would help cover the cost?  

                    • September 4, 2014 at 8:54 pm
                    Scuba Doc
                    Participant

                      Pembrolizumab works just as well as a first line treatment — I wonder if  doctors will be able to get it 'Off Label" soon? And if insurance companies would help cover the cost?  

                      • September 4, 2014 at 8:54 pm
                      Scuba Doc
                      Participant

                        Pembrolizumab works just as well as a first line treatment — I wonder if  doctors will be able to get it 'Off Label" soon? And if insurance companies would help cover the cost?  

                        • July 13, 2014 at 1:36 pm
                        Scuba Doc
                        Participant

                          Why not just Nivolumab alone , when the early test results show an equal or better response using Nivolumab as a mono theraphy vrs.a combination of  Ipi and Nivo??

                          • July 13, 2014 at 1:36 pm
                          Scuba Doc
                          Participant

                            Why not just Nivolumab alone , when the early test results show an equal or better response using Nivolumab as a mono theraphy vrs.a combination of  Ipi and Nivo??

                            • July 13, 2014 at 1:36 pm
                            Scuba Doc
                            Participant

                              Why not just Nivolumab alone , when the early test results show an equal or better response using Nivolumab as a mono theraphy vrs.a combination of  Ipi and Nivo??

                              • June 25, 2014 at 11:26 am
                              Scuba Doc
                              Participant

                                Perhaps with all the new test results Merck will allow melanoma patients to take pembrolizumab regardless of having been previously treated with IPI. I know that some patients opted not to take the IPI for other health reasons. Allowing those patients access to pembrolizumab seem like a no brainer based on the current data.

                                • June 25, 2014 at 11:26 am
                                Scuba Doc
                                Participant

                                  Perhaps with all the new test results Merck will allow melanoma patients to take pembrolizumab regardless of having been previously treated with IPI. I know that some patients opted not to take the IPI for other health reasons. Allowing those patients access to pembrolizumab seem like a no brainer based on the current data.

                                  • June 25, 2014 at 11:26 am
                                  Scuba Doc
                                  Participant

                                    Perhaps with all the new test results Merck will allow melanoma patients to take pembrolizumab regardless of having been previously treated with IPI. I know that some patients opted not to take the IPI for other health reasons. Allowing those patients access to pembrolizumab seem like a no brainer based on the current data.

                                Viewing 1 reply thread
                                1 2 3 4